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aberrant morphology can be rescued by DRP1K38A; however this does
not restore mitochondrial function. gba−/− cells display an increase
in mitochondrial mass and a decrease in basal autophagy levels.
Despite a reduced membrane potential gba−/− neurons and astro-
cytes do not recruit the E3 ubiquitin ligase Parkin, thus mitochondria
are not ﬂagged for turnover and accumulate. Defective autophagy
impinges on the ubiquitin–proteasome system with an increase in
ubiquitinated proteins and p62/sequestosome-1 positive aggregates
in cells lacking gba. There is also a clear reduction in mitochondrial
oxygen consumption levels in gba−/− mice when compared with
controls. Taken together these ﬁndings suggest that cellular dysfunc-
tion observed in GD, like that of PD, is a consequence of defects in
autophagy/mitophagy pathways, resulting in failed clearance of
damaged mitochondria. Knowledge gained from this study may help
elucidate the mechanistic links between GD and PD and in turn, lead
to greater understanding of the disease states themselves.
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Dystrophin is a subsarcolemmal protein critical for the integrity of
muscle ﬁbers by linking the actin cytoskeleton to the extracellular
matrix via the dystroglycan complex (DGC). DGC also occurs at the
dermal–epidermal junction in the skin. Here we report for the ﬁrst
time that epidermal melanocytes express dystrophin. The full-length
muscle isoform of dystrophin (mDp427) was clearly detectable in
skin sections as assessed by RNA analysis. Dystrophin was selectively
expressed at the basal layer of melanocytes where it co-localized with
basement membrane (BM) components. Dystrophin was absent in
the epidermis of Duchenne muscular dystrophy (DMD) patients,
while dystroglycans and BM components were normally expressed.
We have characterized mitochondrial function in primary cultures of
melanocytes from one normal donor and two DMD patients.
Mitochondria readily accumulated tetramethylrhodamine methyl
ester, indicating that they are energized irrespective of the presence
of dystrophin. On the other hand, and at variance from mitochondria
of control donors, mitochondria of DMD patients readily depolarized
upon the addition of oligomycin, suggesting either that they are
maintaining the membrane potential at the expense of glycolytic ATP,
or that they are affected by a latent dysfunction unmasked by
inhibition of the ATP synthase. We are currently investigating the
basis for this anomalous response to oligomycin, which in Ullrich
congenital muscular dystrophy is caused by sensitization of the
permeability transition pore. Since melanocyte cultures can be easily
obtained by conventional skin biopsies, they represent a promising
cellular model for studying and monitoring dystrophinopathies and
their response to experimental treatments.
doi:10.1016/j.bbabio.2012.06.218
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The control of respiration in intact neurons is thought to respond
predominantly to ATP turnover [1]. However, when ATP turnover
increases, substrate supply may also inﬂuence respiration. Different
agonists (high K+ depolarization, veratridine, NMDA) produce
increases in ATP turnover (ATP consumption in ion pumps, such as
Ca2+ ATPase or Na+/K+ ATPase) and increases in cytosolic Ca2+. The
presence of a Ca2+ signal may inﬂuence substrate supply through
effects of Ca2+ on mitochondrial matrix dehydrogenases, an effect
requiring the Ca2+ uniporter, or through effects on the Ca2+
regulated mitochondrial transporters of aspartate/glutamate, aralar/
AGC1, or ATP-Mg/Pi, SCaMC-3. We have studied the role of Ca2+ in
agonist-stimulation of respiration in intact cerebral cortex neurons by
employing neurons derived from aralar/AGC1 KO mice [2] and
SCaMC-3 KO mice in the absence or presence of Ca2+. The absence
of aralar/AGC1, results in a drastic decrease in OCR in neurons in 2.5
or 5 mM glucose, of about 46% of control values, and in a larger drop
in maximal uncoupled respiration, especially in the presence of Ca2+,
consistent with the essential role of this transporter in the malate–
aspartate shuttle (MAS) [2]. However, these neurons still respond to
KCl (30 mM) with an increase in mitochondrial OCR of a smaller
absolute but same relative magnitude as control neurons (about
150%) which was largely blocked in Ca2+-free media. These results
show that the Ca2+ signals produced by K-depolarization are
conveyed to mitochondria through the Ca2+ uniporter-mitochondrial
dehydrogenases pathway and not through aralar/AGC1. In addition,
SCaMC-3 had no effects on high K+-stimulated respiration. Other
agonists, such as NMDA, glutamate or veratridine induce a much
higher increase in respiration partially blocked in Ca2+-free media,
and in SCaMC-3 (Slc25a23) KO neurons. As these agonists trigger
mitochondrial dysfunction, as indicated by the drastic decrease in
maximal uncoupled respiration, the results are likely to reﬂect the
earlier occurrence of mitochondrial dysfunction upon Ca2+ overload
in SCaMC-3 deﬁcient neurons. Indeed, the calcium retention capacity
of isolated brain mitochondria from SCaMC-3 deﬁcient mice incubat-
ed in the presence of ATP-Mg is severely decreased.
Taken together, the results suggest that the role of Ca2+ in the
increase in respiration obtained by agonists inducing Ca2+ signals
and increases in ATP turnover is largely conveyed through the Ca2+-
uniporter–mitochondrial dehydrogenase pathway. The aralar–AGC1–
MAS pathway imposes a critical limit on basal respiration and in
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maximal uncoupled respiration, especially in the presence of calcium,
suggesting that a full Ca2+-dependent activation of aralar–MAS is
required under this condition. On the other hand, SCaMC-3 has no effects
on basal or maximal respiration aids in maintaining a higher and more
sustained respiration under conditions of mitochondrial Ca2+ overload.
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Metformin is a widely prescribed drug used for the treatment of
type 2 diabetes. Previous studies have demonstrated that metformin
speciﬁcally inhibits complex I of the mitochondrial respiratory system
[1,2]. This seems counterproductive since impaired muscle mito-
chondrial function has been linked to the pathogenesis of type 2
diabetes [3,4].
Objective: To investigate the effects of metformin on in vivo and in
vitro skeletal muscle mitochondrial function in Zucker diabetic fatty
(ZDF) rats using 31P magnetic resonance spectroscopy (MRS) and
high-resolution respirometry (HRR), respectively.
Methods: 12-week old healthy (fa/+) and diabetic (fa/fa) ZDF rats
were treated with metformin (0, 30, 100 or 300 mg/kg body weight/
day) for 15 days by oral gavage. At day 14, 31P MRS was performed
on the tibialis anterior (TA) muscle to determine mitochondrial
function in vivo. A time series of 31P spectra was measured before,
during and after muscle contractions to measure PCr recovery rate,
which is an indirect measure of mitochondrial function in vivo.
Muscle contractions were induced by electrical stimulation of the TA,
via subcutaneously implanted electrodes. At day 15, animals were
killed and mitochondria were isolated from excised TA muscles to do
in vitro HRR measurements. Results: Metformin treatment decreased
PCr recovery rates in a dose-dependent manner in both healthy fa/+
and diabetic fa/fa rats. Whereas, the clinical dose of 30 mg/kg/day
had no signiﬁcant effect, PCr recovery rates were ~20% and ~50%
decreased at 100 and 300 mg/kg/day. HRR measurements showed a
similar dose-dependent effect of metformin on in vitromitochondrial
function.
Conclusion: Metformin treatment impairs in vivo skeletal muscle
oxidative capacity in rats in a dose-dependent manner. Since an
impairment of mitochondrial function has been implicated in the
pathogenesis of type 2 diabetes, our results would suggest the clinical
use of metformin to treat type 2 diabetes might need to be reevaluated.
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